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Handled by Zhihua ZhangThe breadth of the enrichment site for post-translational
trimethylation of histone H3 at lysine 4 (H3K4me3) on
chromatin has attracted great attention recently. H3K4me3,
an extensively-studied histone modification, is reported to
promote gene transcription by directing preinitiation complex
assembly through interaction with effector proteins, e.g., the
transcription factor IID (TFIID) complex [1]. Scientists have
been interested in the biological implications of signal density,
but know little about the importance of the breadth of an
H3K4me3 enrichment site. H3K4me3 is usually restricted
within a narrow genomic region of approximately one thou-
sand base pairs, with high signal density around the transcrip-
tion start site (TSS) [2]. However, several groups recently
revealed that this is not always the case. A considerable num-
ber of H3K4me3 enrichment sites can each be broad while
having low signal density. Such broad H3K4me3 domains each
spans a genomic region of at least several thousands of base
pairs [3–7]. H3K4me3 domain that is as wide as hundreds of
thousands of base pairs was reproducibly observed. The upper
limit of H3K4me3 domain width is not clear yet. Results from
multiple cell types in different species consistently providestrong evidence showing that H3K4me3 breadth has its own
biological implications. These findings suggest that the breadth
of H3K4me3 is an unexplored functional epigenetic signal.
Broad H3K4me3 is associated with cell identity
specification and tumor suppression
The broad pattern of H3K4me3 was observed early at some
important genes in several cell types [8–10]. These observations
were, at that time, mainly considered exceptions to the general
sharp, narrow peak of H3k4me3, and were not expected to
have large-scale functional relevance. However, three recent
studies systemically investigated H3K4me3 landscape through
integrative analysis of large dataset, and both independently
revealed that the breadth of enrichment site plays a key role
in determining the functions of H3K4me3 [3,4,11]. Benayoun
et al. [3] performed a large-scale meta-analysis of H3K4me3
and observed a widespread pattern of broad H3K4me3 in mul-
tiple cell lines originating from different species. They demon-
strated that genes marked with the top 5% of the broadest
H3K4me3 domains are enriched in cell type-specific functions
in a given cell type and across species. Both single cell and cell
population datasets demonstrate that broad H3K4me3
domains are associated with increased transcriptional consis-
tence. Chen et al. [4] systematically studied the epigenetic sig-
natures of cancer driver genes by conducting a large-scaleces and
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cancer somatic mutations from >8200 tumor–normal pairs,
and experimental data from clinical samples. They identified
broad H3K4me3 as the first epigenetic signature for tumor
suppressor genes in normal cells. Their data show that broad
H3K4me3 peaks, but not the typical H3K4me3 peaks, are
associated with increased transcription elongation and enhan-
cer activity. Chen et al. [4] also reported a positive correlation
between the broad H3K4me3 and high expression of the asso-
ciated genes. Dincer et al. [11] specifically analyzed H3K4me3
in the human brain, and revealed that the broadest H3K4me3
domains are associated with synaptic signaling, neuronal func-
tions, and developmental disease mechanisms. In agreement
with each other, Benayoun et al. [3], Chen et al. [4], and Dincer
et al. [11] all independently revealed that cell type-specific
broad H3K4me3 domains are associated with cell identity
genes, albeit using different datasets and methodologies. These
studies highlighted for the first time the importance of breadth
in deciphering the H3K4me3 signal.
Broad H3K4me3 is reprogramed dramatically during
pre-implantation embryonic development
Three more recently published studies systematically analyzed
the specific dynamics of broad H3K4me3 in the developing
gamete and pre-implantation embryo, indicating their crucial
function in regulating gene expression at early developmental
stages [5–7]. Epigenome is dramatically reprogramed after fer-
tilization and during early embryonic development. However,
the genome-wide profiling of regions undergoing epigenetic
reprograming remains unexplored, largely due to the scarcity
of cells from early developmental stages. These studies
addressed this technical challenge by developing or improving
highly-sensitive and low-input chromatin immunoprecipita-
tion-sequencing (ChIP-Seq) technologies, with some differ-
ences between studies. These low-input ChIP-Seq
technologies enabled the analysis of histone modifications in
as few as 200 cells. Taking advantage of low-input ChIP-
Seq, several histone modifications, including H3K4me3,
H3K27me3, and H3K27ac, were profiled on a genome-wide
scale in cells from early developmental stages. One consistent
pattern revealed in all three studies is that both the shape
and distribution of H3K4me3 enrichment sites are quite dis-
tinct in cells of early developmental stages when compared
to embryonic stem cells (ESCs) or mature cell types. Specifi-
cally, in early cells (gametes, zygotes, and embryos prior to
the 2-cell stage) H3K4me3 marks usually spread across large
genomic regions, and each spans more than ten thousand base
pairs, with low signal density and large distance from TSS.
This unique pattern of H3K4me3 is termed either broad
H3K4me3 or non-canonical H3K4me3, to be distinguished
from the narrowly-disposed H3K4me3 around the TSS in ES
cells and other mature cell types.
Liu et al. [7] used the low-input ChIP-Seq to profile gen-
ome-wide reprograming of histone modifications H3K4me3
and H3K27me3 during pre-implantation developmental
stages. The authors mapped the two modifications in cells
from metaphase II (MII) oocytes to pre-implantation embryos
at 2-cell, 4-cell, 8-cell, and morula stages, as well as the inner
cell mass (ICM), trophectoderm (TE), ESCs, and trophoblast
stem cells (TSCs). They observed an increase in the numberof genes marked by broad H3K4me3 from 1783 at 2-cell stage
to 5747 and 5932 in ICM and TE, respectively. The number
decreases to 1315 and 1428 in ESCs and TSCs, respectively.
Notably, their method detected only 12 genes associated with
broad H3K4me3 in metaphase II (MII) oocytes. Accordingly,
by knocking down the genes encoding histone demethylases,
e.g., lysine (K)-specific demethylase 5B (KDM5B), to impede
the shortening of broad H3K4me3, the blastocyst formation,
but not the development to the morula, was impaired. The
authors demonstrated that the high dynamic of broad
H3K4me3 occurred mainly between broad and medium status,
and barely between broad and narrow status. In agreement
with the observation by Chen et al. [4], Liu et al. [7] observed
a strong positive correlation between H3K4me3 breadth and
RNA expression. Taken together, the authors suggested that
the dynamics of H3K4me3 breadth might be a novel mecha-
nism of epigenetic regulation in early cleavage embryos.
Employing similar strategies independently, Dahl et al. [5]
and Zhang et al. [6] profiled the genome-wide dynamics of
H3K4me3 along with other chromatin features during pre-
implantation embryonic development. Dahl et al. [5] revealed
that approximately 22% of the oocyte genome is associated
with broad H3K4me3 domains that are negatively correlated
with DNA methylation. They found that H3K4me3 becomes
confined to TSS regions at the 2-cell stage. Zhang et al. [6] also
observed a broad enrichment pattern of H3K4me3 in oocytes,
but instead named this pattern as the non-canonical form of
H3K4me3 (ncH3K4me3). Dahl et al. [5] and Zhang et al. [6]
both highlighted that broad H3K4me3 in oocytes are not gen-
erally located near the TSS. In agreement with Liu et al. [7] and
Benayoun et al. [3], they also demonstrate that the histone
demethylases, e.g., KDM5A and KDM5B, are required for
shortening of broad H3K4me3. They further revealed that
removal of broad H3K4me3 domains is required for normal
zygotic genome activation. Notably, Liu et al. [7] also observed
non-canonical flat H3K4me3 domains with low fold enrich-
ment in oocytes, and reported that these domains are removed
in the 2-cell stage, although they focused mainly on broad
domains that were established during the pre-implantation
development. Overall, these studies highlighted non-canonical
broad H3K4me3 as a key player in the process of dramatic epi-
genetic reprograming in cells at pre-implantation developmen-
tal stages.
Discussion
An intriguing mystery, however, is the biological implications
of the non-canonical broad H3K4me3 domains observed
specifically in oocytes. Zhang et al. [6] highlighted that the glo-
bal occurrence of non-canonical broad H3K4me3 coincides
with genome silencing from mature oocytes to the early 2-cell
stage, raising a paradoxical possibility that it may contribute
to gene repression. They demonstrated that over expression
of histone demethylases leads to significant downregulation
of H3K4me3 and reactivates transcription in a substantial
portion of oocytes. One potential connection between
non-canonical broad H3K4me3 and genome silencing, how-
ever, might be H3K4me3-specifc reader proteins expressed
preferentially in oocytes. Given that canonical H3K4me3 in
other cell types is well known to be associated with transcrip-
tion initiation or elongation, it is a pressing need to unveil the
264 Genomics Proteomics Bioinformatics 14 (2016) 262–264molecular mechanisms underlying the role of non-canonical
H3K4me3 as a repressive mark in oocytes.
There is also a possibility that a technical effect in data nor-
malization might strengthen or weaken the observation of
non-canonical broad H3K4me3 in oocytes. Given that non-
canonical H3K4me3 in oocytes is broader than canonical
H3K4me3 in other cell types, normalizing the total ChIP-Seq
signal to be the same may result in lower density values for
non-canonical H3K4me3 in oocytes. On the other hand,
assuming that non-canonical broad H3K4me3 actually exists
in other cell types too, when the total ChIP-Seq signals were
normalized, the absence of canonical high-density signals in
oocytes might have allowed the non-canonical low-density sig-
nals to be enhanced accordingly. As a result, the normalization
effect might have caused non-canonical broad H3K4me3 to be
observed in oocytes, but continue to be overlooked in other
cell types. It is therefore important to test these two possibili-
ties in future studies using external spike-in sequences as a con-
trol for low-input ChIP-Seq or ChIP-PCR.
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